Literature DB >> 10639458

A Mycobacterium ulcerans toxin, mycolactone, causes apoptosis in guinea pig ulcers and tissue culture cells.

K M George1, L Pascopella, D M Welty, P L Small.   

Abstract

Mycobacterium ulcerans is the causative agent of Buruli ulcer, a tropical ulcerative skin disease. One of the most intriguing aspects of this disease is the presence of extensive tissue damage in the absence of an acute inflammatory response. We recently purified and characterized a macrolide toxin, mycolactone, from M. ulcerans. Injection of this molecule into guinea pig skin reproduced cell death and lack of acute inflammatory response similar to that seen following the injection of viable bacteria. We also showed that mycolactone causes a cytopathic effect on mouse fibroblast L929 cells that is characterized by cytoskeletal rearrangements and growth arrest within 48 h. However, these results could not account for the extensive cell death which occurs in Buruli ulcer. The results presented here demonstrate that L929 and J774 mouse macrophage cells die via apoptosis after 3 to 5 days of exposure to mycolactone. Treatment of cells with a pan-caspase inhibitor can inhibit mycolactone-induced apoptosis. We demonstrate that injection of mycolactone into guinea pig skin results in cell death via apoptosis and that the extent of apoptosis increases as the lesion progresses. These results may help to explain why tissue damage in Buruli ulcer is not accompanied by an acute inflammatory response.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10639458      PMCID: PMC97217          DOI: 10.1128/IAI.68.2.877-883.2000

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  29 in total

1.  The inhibitory action of Mycobacterium ulcerans soluble factor on monocyte/T cell cytokine production and NF-kappa B function.

Authors:  A A Pahlevan; D J Wright; C Andrews; K M George; P L Small; B M Foxwell
Journal:  J Immunol       Date:  1999-10-01       Impact factor: 5.422

2.  Modulation of apoptotic cell death by extracellular matrix proteins and a fibronectin-derived antiadhesive peptide.

Authors:  F Fukai; M Mashimo; K Akiyama; T Goto; S Tanuma; T Katayama
Journal:  Exp Cell Res       Date:  1998-07-10       Impact factor: 3.905

3.  Induction and evasion of host defenses by type 1-piliated uropathogenic Escherichia coli.

Authors:  M A Mulvey; Y S Lopez-Boado; C L Wilson; R Roth; W C Parks; J Heuser; S J Hultgren
Journal:  Science       Date:  1998-11-20       Impact factor: 47.728

4.  The cell cycle-specific growth-inhibitory factor produced by Actinobacillus actinomycetemcomitans is a cytolethal distending toxin.

Authors:  M Sugai; T Kawamoto; S Y Pérès; Y Ueno; H Komatsuzawa; T Fujiwara; H Kurihara; H Suginaka; E Oswald
Journal:  Infect Immun       Date:  1998-10       Impact factor: 3.441

5.  Mycolactone: a polyketide toxin from Mycobacterium ulcerans required for virulence.

Authors:  K M George; D Chatterjee; G Gunawardana; D Welty; J Hayman; R Lee; P L Small
Journal:  Science       Date:  1999-02-05       Impact factor: 47.728

6.  Partial purification and characterization of biological effects of a lipid toxin produced by Mycobacterium ulcerans.

Authors:  K M George; L P Barker; D M Welty; P L Small
Journal:  Infect Immun       Date:  1998-02       Impact factor: 3.441

7.  Involvement of the Fas/Fas ligand pathway in activation-induced cell death of mycobacteria-reactive human gamma delta T cells: a mechanism for the loss of gamma delta T cells in patients with pulmonary tuberculosis.

Authors:  B Li; H Bassiri; M D Rossman; P Kramer; A F Eyuboglu; M Torres; E Sada; T Imir; S R Carding
Journal:  J Immunol       Date:  1998-08-01       Impact factor: 5.422

8.  Recognition and phagocytosis of apoptotic cells.

Authors:  L Dini; M T Ruzittu; L Falasca
Journal:  Scanning Microsc       Date:  1996

9.  Dual signaling of the Fas receptor: initiation of both apoptotic and necrotic cell death pathways.

Authors:  D Vercammen; G Brouckaert; G Denecker; M Van de Craen; W Declercq; W Fiers; P Vandenabeele
Journal:  J Exp Med       Date:  1998-09-07       Impact factor: 14.307

10.  Different interleukin-1 beta converting enzyme (ICE) family protease requirements for the apoptotic death of T lymphocytes triggered by diverse stimuli.

Authors:  A Sarin; M L Wu; P A Henkart
Journal:  J Exp Med       Date:  1996-12-01       Impact factor: 14.307

View more
  104 in total

1.  Using bioluminescence to monitor treatment response in real time in mice with Mycobacterium ulcerans infection.

Authors:  Tianyu Zhang; Si-Yang Li; Paul J Converse; Deepak V Almeida; Jacques H Grosset; Eric L Nuermberger
Journal:  Antimicrob Agents Chemother       Date:  2010-11-15       Impact factor: 5.191

Review 2.  Treating Mycobacterium ulcerans disease (Buruli ulcer): from surgery to antibiotics, is the pill mightier than the knife?

Authors:  Paul J Converse; Eric L Nuermberger; Deepak V Almeida; Jacques H Grosset
Journal:  Future Microbiol       Date:  2011-10       Impact factor: 3.165

3.  Buruli ulcer.

Authors:  Mark Wansbrough-Jones; Richard Phillips
Journal:  BMJ       Date:  2005-06-18

4.  Escherichia coli cytotoxic necrotizing factor 1 blocks cell cycle G2/M transition in uroepithelial cells.

Authors:  Loredana Falzano; Perla Filippini; Sara Travaglione; Alessandro Giamboi Miraglia; Alessia Fabbri; Carla Fiorentini
Journal:  Infect Immun       Date:  2006-07       Impact factor: 3.441

5.  Mycobacterium ulcerans triggers T-cell immunity followed by local and regional but not systemic immunosuppression.

Authors:  Alexandra G Fraga; Andrea Cruz; Teresa G Martins; Egídio Torrado; Margarida Saraiva; Daniela R Pereira; Wayne M Meyers; Françoise Portaels; Manuel T Silva; António G Castro; Jorge Pedrosa
Journal:  Infect Immun       Date:  2010-10-25       Impact factor: 3.441

Review 6.  Buruli ulcer: reductive evolution enhances pathogenicity of Mycobacterium ulcerans.

Authors:  Caroline Demangel; Timothy P Stinear; Stewart T Cole
Journal:  Nat Rev Microbiol       Date:  2009-01       Impact factor: 60.633

7.  Analysis of Mycobacterium species for the presence of a macrolide toxin, mycolactone.

Authors:  Alexa K Daniel; Richard E Lee; Francoise Portaels; P L C Small
Journal:  Infect Immun       Date:  2004-01       Impact factor: 3.441

8.  High-Dose Rifamycins Enable Shorter Oral Treatment in a Murine Model of Mycobacterium ulcerans Disease.

Authors:  Till F Omansen; Deepak Almeida; Paul J Converse; Si-Yang Li; Jin Lee; Ymkje Stienstra; Tjip van der Werf; Jacques H Grosset; Eric L Nuermberger
Journal:  Antimicrob Agents Chemother       Date:  2019-01-29       Impact factor: 5.191

9.  Differences in virulence and immune response induced in a murine model by isolates of Mycobacterium ulcerans from different geographic areas.

Authors:  R Hurtado Ortiz; D Aguilar Leon; H Orozco Estevez; A Martin; J Luna Herrera; L Flores Romo; F Portaels; R Hernandez Pando
Journal:  Clin Exp Immunol       Date:  2009-08       Impact factor: 4.330

Review 10.  The chemistry and biology of mycolactones.

Authors:  Matthias Gehringer; Karl-Heinz Altmann
Journal:  Beilstein J Org Chem       Date:  2017-08-11       Impact factor: 2.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.